Medtronic Medical Technology

Medtronic, Inc. a global medical technology leader, announced on 27 March 2017 the official opening of its new 200,000 sq. ft. regional plant office building in the Caohejing Export Processing Zone in Shanghai, China. The new facility is a symbol of Medtronic's permanent presence in China, officially opened as the first biologic heart valve manufacturing site in Greater China, signifying the company's blueprint for further localisation in China, including local product development and manufacturing. Mike Coyle, Group Executive Vice President and Group President, Cardiovascular Business Group, said: "I am very pleased to see Medtronic have a permanent home in China, with a very well built factory and strong support from the local government, which means we will have a platform for future growth at a higher level as we better fulfil our corporate role in China and accomplish our mission of providing the Chinese people with the opportunity to live mission of alleviating suffering, restoring health and extending life."

The project uses SpecPU solvent-free polyurethane self-levelling solution with a polyurethane overlay. Anti-corrosion, dust-free, abrasion-resistant, easy to construct and quick to put into use. Creating a flooring that fully meets the requirements of biological heart valve manufacturing. The owner, Medtronic, expressed its satisfaction: this plant is one of the best I've seen!